228 related articles for article (PubMed ID: 33368660)
1. Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.
Huang Z; Lu X; Huang L; Zhang C; Veldhuis JD; Cowley MA; Chen C
FASEB J; 2021 Jan; 35(1):e21269. PubMed ID: 33368660
[TBL] [Abstract][Full Text] [Related]
2. Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
Mosa R; Huang L; Wu Y; Fung C; Mallawakankanamalage O; LeRoith D; Chen C
Endocrinology; 2017 Oct; 158(10):3174-3187. PubMed ID: 28977588
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.
Zhang X; Yang JK; Chen C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297647
[TBL] [Abstract][Full Text] [Related]
4. Time-Restricted Feeding Restored Insulin-Growth Hormone Balance and Improved Substrate and Energy Metabolism in MC4RKO Obese Mice.
Wang W; Huang Z; Huang L; Gao L; Cui L; Cowley M; Guo L; Chen C
Neuroendocrinology; 2022; 112(2):174-185. PubMed ID: 33735897
[TBL] [Abstract][Full Text] [Related]
5. Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.
Tan HY; Steyn FJ; Huang L; Cowley M; Veldhuis JD; Chen C
J Physiol; 2016 Dec; 594(24):7309-7326. PubMed ID: 27558671
[TBL] [Abstract][Full Text] [Related]
6. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
[TBL] [Abstract][Full Text] [Related]
7. Effect of Growth Hormone Secretagogue Receptor Deletion on Growth, Pulsatile Growth Hormone Secretion, and Meal Pattern in Male and Female Mice.
Labarthe A; Zizzari P; Fiquet O; Lebrun N; Veldhuis JD; Roelfsema F; Chauveau C; Bohlooly-Y M; Epelbaum J; Tolle V
Neuroendocrinology; 2022; 112(3):215-234. PubMed ID: 33774644
[TBL] [Abstract][Full Text] [Related]
8. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone.
Conley LK; Brogan RS; Giustina A; Wehrenberg WB
Pituitary; 2000 May; 2(4):253-60. PubMed ID: 11081146
[TBL] [Abstract][Full Text] [Related]
9. Suppression of hyperinsulinemia restores growth hormone secretion and metabolism in obese mice.
Huang Z; Lu X; Huang L; Chen Y; Zhang C; Veldhuis JD; Chen C
J Endocrinol; 2021 Jul; 250(3):105-116. PubMed ID: 34156345
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro.
Liu Q; Lei T; Liu K; Lin W; Adams EF
J Tongji Med Univ; 2000; 20(2):109-11. PubMed ID: 12845719
[TBL] [Abstract][Full Text] [Related]
11. Effect of Deletion of Ghrelin-O-Acyltransferase on the Pulsatile Release of Growth Hormone in Mice.
Xie TY; Ngo ST; Veldhuis JD; Jeffery PL; Chopin LK; Tschöp M; Waters MJ; Tolle V; Epelbaum J; Chen C; Steyn FJ
J Neuroendocrinol; 2015 Dec; 27(12):872-86. PubMed ID: 26442444
[TBL] [Abstract][Full Text] [Related]
12. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
Maccario M; Arvat E; Procopio M; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
Metabolism; 1995 Jan; 44(1):134-8. PubMed ID: 7854159
[TBL] [Abstract][Full Text] [Related]
13. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.
Stanley TL; Grinspoon SK
Growth Horm IGF Res; 2015 Apr; 25(2):59-65. PubMed ID: 25555516
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
16. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
17. Physiological studies of transgenic mice overexpressing growth hormone (GH) secretagogue receptor 1A in GH-releasing hormone neurons.
Lall S; Balthasar N; Carmignac D; Magoulas C; Sesay A; Houston P; Mathers K; Robinson I
Endocrinology; 2004 Apr; 145(4):1602-11. PubMed ID: 14701677
[TBL] [Abstract][Full Text] [Related]
18. The effect of body composition on hexarelin-induced growth hormone release in normal elderly subjects.
Rahim A; O'Neill P; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):659-64. PubMed ID: 10197083
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone in obesity.
Scacchi M; Pincelli AI; Cavagnini F
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
[TBL] [Abstract][Full Text] [Related]
20. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
